Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Repaglinide with Insulin BIAsp30 in Non-Obese T2D
NCT00118963Phase 4Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Jan 2003
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Steno Diabetes Center Copenhagen. Started Jan 2003; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00118963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118963.